Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-19 Dissanaike Sharmila Director Grant or award +13,948 69,230
2024-01-19 Dissanaike Sharmila Director Grant or award · Stock Option (Right to Buy) +83,685 83,685
2024-01-19 Peraza Lisa VP, Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +41,078 41,078
2024-01-19 Peraza Lisa VP, Chief Accounting Officer Grant or award · Restricted Stock Units +6,846 6,846
2024-01-19 Forbes William P EVP, Chief Development Officer Grant or award · Employee Stock Option (Right to Buy) +371,935 371,935
2024-01-19 Forbes William P EVP, Chief Development Officer Grant or award · Restricted Stock Units +61,989 61,989
2024-01-19 Duarte Ira EVP, Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +371,935 371,935
2024-01-19 Duarte Ira EVP, Chief Financial Officer Grant or award · Restricted Stock Units +61,989 61,989
2024-01-19 Collard Craig A Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +1,324,502 1,324,502
2024-01-19 Collard Craig A Chief Executive Officer Grant or award · Restricted Stock Units +220,750 220,750
2024-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +552 55,374
2024-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +1,289 56,663
2024-01-13 Peraza Lisa VP, Chief Accounting Officer Shares withheld for taxes −756 $2.15 $2K 55,907
2024-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −552 1,656
2024-01-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −1,289 6,675
2023-11-17 Forbes William P EVP, Chief Development Officer Purchase +25,000 $1.09 $27K 79,000
2023-11-16 Forbes William P EVP, Chief Development Officer Purchase +50,000 $0.94 $47K 54,000
2023-11-16 Collard Craig A Chief Executive Officer Purchase +150,000 $0.92 $138K 186,496
2023-11-16 Duarte Ira EVP, Chief Financial Officer Purchase +85,000 $0.89 $76K 85,000
2023-10-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +552 53,750

Page 13 of 28 · 557 trades